###begin article-title 0
Molecular Plasticity of E-Cadherin and Sialyl Lewis X Expression, in Two Comparative Models of Mammary Tumorigenesis
###end article-title 0
###begin p 1
Conceived and designed the experiments: SSP CAR FG MLA. Performed the experiments: SSP MLA. Analyzed the data: SSP CAR FG MLA. Contributed reagents/materials/analysis tools: SSP. Wrote the paper: SSP MLA. Contributed strongly to the revision of the manuscript: CAR FG.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x/a</sup>
The process of metastasis involves a series of steps and interactions between the tumor embolus and the microenvironment. Key alterations in adhesion molecules are known to dictate progression from the invasive to malignant phenotype followed by colonization at a distant site. The invasive phenotype results from the loss of expression of the E-cadherin adhesion molecule, whereas the malignant phenotype is associated with an increased expression of the carbohydrate ligand-binding epitopes, (e.g. Sialyl Lewis x/a) that bind endothelial E-selectin of the lymphatics and vasculature.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 95 96 95 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 138 143 <span type="species:ncbi:9606">human</span>
Our study analyzed the expression of two adhesion molecules, E-cadherin and Sialyl Lewis x (sLex), in both a canine mammary carcinoma and human inflammatory breast cancer (IBC) model, using double labelled immunofluorescence staining.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 141 142 141 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 58 63 <span type="species:ncbi:9606">human</span>
Our results demonstrate that canine mammary carcinoma and human IBC exhibit an inversely correlated cellular expression of E-cadherin and sLex within the same tumor embolus.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 146 147 146 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Our results in these two comparative models (canine and human) suggest the existence of a biologically coordinated mechanism of E-cadherin and sLex expression (i.e. molecular plasticity) essential for tumor establishment and metastatic progression.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 194 197 194 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Woodhouse1">[1]</xref>
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Liotta1">[2]</xref>
###xml 317 320 317 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Joyce1">[3]</xref>
###xml 525 528 525 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Liotta2">[4]</xref>
Metastasis is classically defined as the lymphatic or haematogenous (blood-born) dissemination of cancer cells from the primary tumor (origin) to lymph nodes and/or to distant sites in the body [1]. The process involves a complex series of steps and interactions between the tumor cells and the microenvironment [2], [3]. The terminal step of this sequential process is colonization of the tumor cells at distant sites in the body. The tendency of aggressive cancers to metastasize is the cause of mortality from the disease [4]. Determining the molecular mechanisms of metastasis is of the utmost importance in an attempt to manage and treat cancer.
###end p 11
###begin p 12
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Eccles1">[5]</xref>
###xml 494 497 494 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Scheel1">[6]</xref>
###xml 499 502 499 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Talmadge1">[7]</xref>
###xml 665 668 665 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Scheel1">[6]</xref>
###xml 894 897 894 897 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Wodarz1">[8]</xref>
###xml 899 902 899 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-VincentSalamon1">[9]</xref>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Couldrey1">[10]</xref>
Although all cells of the tumor embolus arise from the same parent cell, the embolus is composed of a heterogeneous population of cells. Even in the most malignant primary tumor not all cells have the capability of successfully colonizing at a distant site [5]. This diversity, as well as the molecular and cellular mechanisms underlying the metastatic potential of the tumor embolus result from inherent (clonal selection) or acquired (adaptive) traits or both of the tumor cells composing it [6], [7]. Only a portion of those heterogeneous cells progress to the malignant phenotype and even a smaller portion can successfully colonize, and form deadly metastases [6]. The ability of those tumor cells to conform to new environments is due to a molecular plasticity. Among the events involved in molecular plasticity, loss and gain of key adhesion molecules appears to be a significant factor [8], [9]. Key alterations in adhesion molecules are known to dictate progression from the invasive to malignant phenotype followed by colonization at a distant site [10].
###end p 12
###begin p 13
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-VincentSalamon1">[9]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Beavon1">[11]</xref>
###xml 285 286 285 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 507 511 507 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Kannagi1">[12]</xref>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Wang1">[13]</xref>
###xml 522 523 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 635 639 635 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Miyagi1">[14]</xref>
###xml 641 645 641 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Varki1">[15]</xref>
E-cadherin and Sialyl Lewis x (sLex) are two adhesion molecules that govern malignant progression. E-cadherin is an adhesion molecule that plays a key role in homotypic cell-cell adhesion, being classically considered a potent invasion/tumor suppressor gene [9], [11]. Furthermore, sLex antigen is a carbohydrate structure that is involved in selectin-mediated adhesion of cancer cells to vascular endothelium and this determinant is thought to be closely associated with haematogenous metastases of cancer [12], [13]. sLex not only is a marker for cancer but also is functionally implicated in the malignant behaviour of cancer cells [14], [15]. Overall, the loss and gain of expression of these molecules are not aberrant variations, but adaptive mechanisms of the cancer embolus, which can defeat our present treatment modalities.
###end p 13
###begin p 14
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Paoloni1">[16]</xref>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Owen1">[17]</xref>
###xml 43 49 <span type="species:ncbi:9606">humans</span>
###xml 343 348 <span type="species:ncbi:9606">women</span>
Naturally occurring cancers in canines and humans share many features, including histological appearance, tumor genetics, molecular targets, biological behaviour and response to conventional therapies [16]. Mammary carcinomas, specifically, occur among all taxonomic groups, and comparing the disease in canine models with breast carcinoma in women could greatly improve our understanding of the molecular biology underlying the process of mammary tumorigenesis and progression [17].
###end p 14
###begin p 15
###xml 193 194 193 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 122 127 <span type="species:ncbi:9606">women</span>
In this report we demonstrate that canine mammary carcinoma and the highly metastatic inflammatory breast cancer (IBC) in women, exhibit an inversely correlated expression of E-cadherin and sLex in cells of the same tumor embolus. Both mammary carcinoma models support a coordinated expression between the two adhesion molecules, suggesting a dynamic transition state or molecular plasticity promoting tumor survival and dissemination during the metastatic progression.
###end p 15
###begin title 16
Materials and Methods
###end title 16
###begin title 17
Ethics Statement
###end title 17
###begin p 18
All experiments were performed in compliance with the Memorial Sloan-Kettering Cancer Center Animal Care and Use Program (Protocol Number 06-04-006).
###end p 18
###begin title 19
MARY-X Xenograft and in vitro spheroids
###end title 19
###begin p 20
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Alpaugh1">[18]</xref>
###xml 82 89 82 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 203 211 203 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 481 488 481 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1083 1084 1041 1042 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 30 37 <span type="species:ncbi:9606">patient</span>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 972 978 <span type="species:ncbi:9913">bovine</span>
MARY-X was established from a patient with inflammatory breast cancer (IBC) [18]. In vivo, MARY-X recapitulates the human IBC phenotype of extensive lymphovascular invasion of the tumor cell emboli. The in vitro MARY-X spheroids are prepared by mincing the extricated tumor followed by an overnight incubation under standard tissue culture conditions. The IBC cells are released as sheets and small spheroids initially. Over a period of time, roughly 12-14 hours, the IBC cells as in vivo, begin to overexpress E-cadherin and form tight, compact spheroids in suspension. The compact, multicellular in cell suspension spheroids are further purified by partitioning through various size (100 microm, 70 microm and 40 microm pore size; BD Biosciences) cell strainers to produce homogenous preparations of spheroid sizes of 40 microm-70 microm, 70 microm-100 microm and 100+ microm in diameter. Spheroids were maintained in minimal essential medium (MEM) containing 10% fetal bovine serum and antibiotics (100 U/ml penicillin and 100 microg/ml streptomycin) at 37degreesC in an air-5% CO2 atmosphere at constant humidity.
###end p 20
###begin title 21
Canine mammary carcinoma cell line, CMT-U27
###end title 21
###begin p 22
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Hellmn1">[19]</xref>
###xml 238 242 238 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">nude</italic>
###xml 549 550 539 540 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 238 247 <span type="species:ncbi:10090">nude mice</span>
###xml 409 415 <span type="species:ncbi:9913">bovine</span>
The canine mammary carcinoma cell line CMT-U27 was obtained from the Uppsala University, Sweden. CMT-U27 cell line was derived from a primary tumor (infiltrating ductal carcinoma) [19] and when inoculated in the fat mammary pad of female nude mice metastasizes to the lymph nodes, lungs, liver and heart. CMT-U27 was cultured in RPMI 1640 with Glutamax medium (Gibco, Invitrogen), supplemented with 10% fetal bovine serum (Gibco, Invitrogen) and 50 microg/ml gentamicin (Gibco, Invitrogen). Culture was maintained at 37degreesC in a humidified 5% CO2 atmosphere.
###end p 22
###begin title 23
Tissue specimens
###end title 23
###begin p 24
###xml 477 481 477 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Pea1">[20]</xref>
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-PrezAlenza1">[21]</xref>
###xml 616 623 616 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 676 684 676 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
Ten tissue samples of primary canine mammary carcinomas of different histological types (3 Complex carcinomas; 3 Tubulopapillary carcinomas; 2 Carcinosarcoma; 2 Solid carcinomas) and 3 correspondent lung metastases were used in this study. Accordingly with Pena L et al., canine inflammatory mammary carcinoma (IMC) once diagnosed is involved with other histological types of canine mammary carcinoma including solid carcinomas, tubulopapillary carcinomas and sarcomatous type [20]. The same is also true for feline IMC where the histology revealed types of tubulopapillary mammary carcinomas [21]. In addition, ten in vivo (primary tumor and metastases in SCID mice) and ten in vitro specimens were harvested from the MARY-X model. The specimens were fixed in 10% neutral buffered formalin. After dehydration and paraffin wax embedment, 4 microm thick sections were cut from each representative paraffin block for staining with haematoxylin and eosin and for double-staining immunofluorescence.
###end p 24
###begin title 25
Double-Labelling Immunofluorescence
###end title 25
###begin p 26
###xml 37 38 37 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
For simultaneous visualization of sLex and E-cadherin on the same tissue section of the two comparative models, MARY-X and canine mammary gland carcinomas, double-label immunofluorescence technique was performed.
###end p 26
###begin p 27
###xml 347 353 <span type="species:ncbi:9986">rabbit</span>
###xml 411 417 <span type="species:ncbi:9913">bovine</span>
###xml 518 523 <span type="species:ncbi:9606">human</span>
###xml 703 709 <span type="species:ncbi:9986">rabbit</span>
###xml 715 720 <span type="species:ncbi:10090">mouse</span>
###xml 868 872 <span type="species:ncbi:9925">goat</span>
###xml 950 955 <span type="species:ncbi:10090">mouse</span>
###xml 1093 1097 <span type="species:ncbi:9925">goat</span>
###xml 1103 1108 <span type="species:ncbi:10090">mouse</span>
Briefly, paraffin sections were dewaxed, rehydrated and then treated with Extran (Merck, Frankfurt, Germany) 0.05% in distilled water for 10 min in a microwave oven at 750 W. After being left to cool for 20 min at room temperature, slides were rinsed twice in Phosphate-buffered saline (PBS), and then incubated for 20 min in a humid chamber with rabbit non-immune serum at a dilution 1:5 in PBS containing 10% bovine serum albumin (BSA). Sections were incubated with the first primary monoclonal antibody (mAb), anti-human E-Cadherin (clone 36, BD Biosciences Pharmingen, diluted 1:100 in PBS), overnight at 4degreesC. After washing twice for 5 min in PBS, sections were incubated with FITC-conjugated rabbit anti-mouse immunoglobulin (code F261; Dako, Glostrup, Denmark; diluted 1:100 in PBS). Sections were washed twice for 5 min in PBS and blocked with non-immune goat serum diluted 1:5 in PBS containing BSA 10%. After incubation with mAb KM93 (mouse IgM) diluted at 1:40, overnight at 4degreesC, sections were washed twice for 5 min with PBS and then incubated with Texas red-conjugated goat anti-mouse IgM (Jackson Immunoresearch) diluted 1:50 in PBS. Sections were washed as before and nuclei were counterstained with 4'-6-Diamidino-2-phenylindole (DAPI, Sigma) diluted at 1:100 in PBS, for 15 min in the dark. Finally, sections were washed twice for 5 min in PBS and mounted with Vectashield (Vector Laboratories, Burlingame, USA).
###end p 27
###begin p 28
Dilutions of primary antibodies, secondary antibodies, and DAPI were made with PBS containing 5% BSA.
###end p 28
###begin p 29
Immunostained tissue sections were examined under a fluorescence microscope (Leica DMIRE2) equipped with appropriate filters. Separate images for DAPI, Texas-Red and FITC staining were captured digitally at X200 and X400 magnification. The red (for Texas-Red), blue (for DAPI), and green (for FITC) components were merged and combined images were imported into Adobe Photoshop(R).
###end p 29
###begin title 30
Immunoprecipitation of E-cadherin from CMT-U27
###end title 30
###begin p 31
###xml 222 223 222 223 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 225 226 225 226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Cells from CMT-U27 cell line were washed with cold phosphate-buffered saline (PBS) and then lysed with a lysis buffer (1% (v/v) Triton X-100; 1% (v/v) NP-40 in PBS, containing protease inhibitor cocktail (Roche), 100 mM Na3VO4, 100 mM PMSF) for 15 min on ice. After scraping cell monolayers with a rubber policeman the suspension was centrifuged at 14000 rpm for 10 min at 4degreesC. Protein concentrations were determined by using a BCA protein assay kit (Pierce).
###end p 31
###begin p 32
Total protein (750 microg) of canine cell line was precleared with 50 microl of protein G-sepharose beads (Sigma Aldrich) at 4degreesC under agitation for 1-2 h to remove non-specific adsorption to the sepharose beads.
###end p 32
###begin p 33
###xml 461 462 439 440 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 463 464 441 442 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 465 466 443 444 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 191 196 <span type="species:ncbi:10090">mouse</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
After centrifugation at 14000 rpm for 5 min at 4degreesC, supernatant was incubated overnight at 4degreesC under agitation with 5 microg of monoclonal antibody against E-cadherin (monoclonal mouse anti human E-cadherin, clone 36, BD Biosciences Pharmingen). Then, incubation with protein G-sepharose at 4degreesC for 2 h with agitation was performed. Next, the beads were washed three times with an immunoprecipitation buffer (10% (v/v) lysis buffer, 5 mg/ml Na4P2O7, 1% (v/v) NaF 100X in PBS). The immune complexes were released by boiling 5 min at 95degreesC in Laemmli sampling buffer prior to analyses by Western.
###end p 33
###begin p 34
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
For sLex carbohydrate detection of E-cadherin immunoprecipitated, nitrocellulose membrane was blocked and then incubated with monoclonal antibody that specifically recognizes sLex epitope (KM93) with a dilution of 1 microg/ml in PBS with 0.01% Tween 20 (PBS T) with 5% milk.
###end p 34
###begin p 35
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
The membrane was washed three times with PBS T and incubated with HRP-conjugated anti-mouse IgM secondary antibody (Santa Cruz Biotechnology, 1:3000 diluted in PBS T with 5% milk) during 1 h at room temperature. After washing three times with PBS T, membrane was developed by an ECL according to the manufacturer's recommended protocol.
###end p 35
###begin title 36
Results
###end title 36
###begin title 37
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
Inversely correlated cellular expression of E-cadherin and sLex in the MARY-X spheroid
###end title 37
###begin p 38
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Alpaugh1">[18]</xref>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 212 221 212 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g001">Figure 1A</xref>
###xml 227 234 227 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 348 352 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Tomlinson1">[22]</xref>
###xml 495 496 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 532 536 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Alpaugh2">[23]</xref>
###xml 538 542 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Alpaugh3">[24]</xref>
###xml 810 811 803 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 929 937 922 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1013 1022 1006 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g001">Figure 1B</xref>
###xml 1108 1109 1101 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1128 1144 1121 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g001">Figure 1C and 1D</xref>
###xml 1198 1206 1191 1199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1247 1248 1240 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1272 1281 1265 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g001">Figure 1D</xref>
###xml 1440 1441 1433 1434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1523 1524 1516 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1524 1528 1517 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Alpaugh2">[23]</xref>
###xml 1899 1903 1892 1896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Pinho1">[25]</xref>
###xml 47 53 <span type="species:ncbi:10090">murine</span>
MARY-X, like IBC, grows exclusively within the murine lymphatics and blood vessels, which is the signature phenotype of this highly aggressive, malignant breast carcinoma [18]. Both the MARY-X in vitro spheroid (Figure 1A) and in vivo tumor embolus [data not shown] form on the basis of an intact, over-expressed E-cadherin/alpha,beta catenin axis [22]. Interestingly, MARY-X displays a unique relationship of two key adhesion molecules; over-expression of E-cadherin and under-expression of sLex confirmed by western blot analysis [23], [24]. This relationship is contrary to what would be expected in a highly malignant carcinoma. To determine if expression levels were due to a homogenous population of cellular expression (i.e. each cell produced excessive amounts of E-cadherin and a limited amount of sLex) double-labeling immunofluorescence of the two adhesion molecules was performed. The majority of cells of the MARY-X in vitro spheroid displayed membrane-positioned E-cadherin (green) expression only (Figure 1B). A minority population co-expresses both molecules with a cytoplasmic-positioned sLex (red) expression (Figure 1C and 1D). An even smaller population of cells, of the MARY-X in vitro spheroid display membrane-positioned sLex (red) expression only (Figure 1D). Co-expression of these two adhesion molecules is rarely seen. Hence the MARY-X spheroid displays an inverse relationship of expression of E-cadherin and sLex. Previous studies indicated a cooperative relationship between E-cadherin and sLex[23]. However, our study shows that the expression levels are not due to a homogenous population of cellular expression but rather a heterogeneous population of cellular expression. A similar inversely correlated cellular expression between these two key adhesion molecules has also been reported in a malignant canine mammary carcinoma model and was the basis of this study [25].
###end p 38
###begin title 39
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
Expression of E-cadherin and sLex in the MARY-X spheroid.
###end title 39
###begin p 40
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 363 364 363 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 383 384 383 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
(A) MARY-X in vitro spheroid forms a compact, clump of cells due to over-expression of a key adhesion molecule, E-cadherin (light microscopy; 40x magnification). (B) Illustrates a heterogeneous population of cellular expression with a dominant population of cells expressing membrane-positioned E-cadherin (green) and a minority population of cells expressing sLex (red). (C & D) sLex was found to be either cytoplasmic- (long arrows) or membrane-positioned (blunt arrows).
###end p 40
###begin title 41
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
Inversely correlated cellular expression of E-cadherin and sLex throughout the metastatic progression of MARY-X and canine mammary carcinoma
###end title 41
###begin p 42
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 537 538 537 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 540 554 540 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2A &amp; 2B</xref>
###xml 589 590 589 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 652 666 652 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2A &amp; 2B</xref>
###xml 698 706 698 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 793 802 793 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2A</xref>
###xml 883 884 883 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 902 911 902 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2A</xref>
###xml 1010 1011 1010 1011 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1075 1076 1075 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1127 1136 1127 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2B</xref>
###xml 1322 1336 1322 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2A &amp; 2B</xref>
###xml 1354 1363 1354 1363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2C</xref>
###xml 1389 1390 1389 1390 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1512 1513 1512 1513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1524 1533 1524 1533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2A</xref>
###xml 1615 1616 1615 1616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 1640 1649 1640 1649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2B</xref>
###xml 1667 1676 1667 1676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g002">Figure 2C</xref>
Since adhesion molecules dictate metastatic progression of carcinomas, double labeling immunofluorescence of E-cadherin and sLex was performed on the primary tumor and corresponding metastases of both the MARY-X and canine mammary carcinoma models to determine the presence of a correlated cellular expression throughout metastatic progression. The majority of the cell population of the primary tumor of both the MARY-X and canine models display a strong membrane-positioned E-cadherin (green) expressing cells with no expression of sLex (Figure 2A & 2B). To a lesser extent, nests of sLex (red) expressing cells could be seen throughout both models (Figure 2A & 2B). In the MARY-X model, as seen in vitro, sLex is cytoplasmic-positioned and co-expressed with membrane-positioned E-cadherin (Figure 2A; middle panel). However, a small number of cells display membrane-positioned sLex expression only (Figure 2A; middle panel). The canine primary tumor is very comparable to MARY-X except that the nests of sLex expressing cells predominantly display membrane- positioned sLex only, i.e. no co-expression of the two molecules (Figure 2B; middle panel). The corresponding metastasis of MARY-X and the canine mammary carcinoma also show a dominant population of cells expressing only membrane-positioned E-cadherin (green) (Figure 2A & 2B; right panel and Figure 2C). However, in the few sLex expressing cells of the MARY-X metastasis co-expression of membrane-positioned E-cadherin with cytoplasmic-positioned sLex was seen (Figure 2A; right panel). The canine metastasis showed predominantly membrane-positioned sLex expressing only cells (Figure 2B; right panel and Figure 2C). In the primary tumor and corresponding metastases of both models, co-expression is a rare event. Therefore both models maintain a heterogeneous population of cellular expression through out the metastatic progression displaying an inversely correlated cellular expression of these two key adhesion molecules.
###end p 42
###begin title 43
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
Expression of E-cadherin and sLex throughout the metastatic progression of MARY-X and canine mammary carcinoma.
###end title 43
###begin p 44
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 385 386 385 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 660 661 660 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 890 891 890 891 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 954 955 954 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
(A, B) Shows a heterogeneous population of cellular expression in both (A) MARY-X primary tumors and (B) canine primary tumors (carcinosarcoma and solid carcinoma) displaying a dominant population of cells with membrane-positioned E-cadherin (green) and smaller nests sLex (red) expressing cells (cytoplasmic or membrane-positioned). (A, B; middle panels) Magnified image shows the sLex found either cytoplasmic- (long arrows) or membrane-positioned (blunt arrows). Mary-X lung metastasis (MARY-X metastasis) displays a dominant population of cells expressing only E-cadherin (green), and a minority population of cells co-expressing cytoplasmic-positioned sLex (red) (long arrows). (B, C) Canine lung metastasis (Canine metastasis) displays a dominant population of cells expressing only E-cadherin (green), and minority populations of cells either co-expressing cytoplasmic-positioned sLex (red) (long arrows) or expressing only membrane-positioned sLex (red) (blunt arrows).
###end p 44
###begin title 45
Sialyl-Lewis X does not mask E-cadherin expression
###end title 45
###begin p 46
###xml 98 99 98 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 197 198 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 364 365 364 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 438 439 438 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 612 620 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006636-g003">Figure 3</xref>
###xml 673 674 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
An E-cadherin immunoprecipitation (IP) was performed in order to rule out the possibility that sLex immunofluorescense (red) masked E-cadherin immunofluorescense (green) in cells that displayed sLex expression only (i.e. E-cadherin is a carrier of sLex). This approach was only performed on the canine model due to the greater number of cells that express only sLex as compared to the MARY-X model. The evaluation of the expression of sLex using a specific monoclonal antibody showed no detection of this carbohydrate antigen on the E-cadherin immunoprecipitate from canine mammary carcinoma cell line, CMT-U27 (Figure 3). This finding excludes the possibility that the sLex carbohydrate is attached to E-cadherin.
###end p 46
###begin title 47
E-cadherin immunoprecipitation of CMT-U27 cell line.
###end title 47
###begin p 48
###xml 93 94 93 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
The left lane shows the E-cadherin immunoprecipitate. The right lane shows the absence of sLex in the E-cadherin immunoprecipitate. The 50 kDa bands in both lanes are the immunoglobulin heavy chain.
###end p 48
###begin title 49
Discussion
###end title 49
###begin p 50
###xml 205 208 205 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Liotta2">[4]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Beavon1">[11]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Kannagi1">[12]</xref>
###xml 711 712 711 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
###xml 712 716 712 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Pinho1">[25]</xref>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006636-Ferrara1">[26]</xref>
###xml 926 927 926 927 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
zTumor cell formation and development of metastasis is a multistep process involving complex interactions between cancer cells, extracellular matrix, lymphovascular system, immune system and target organs [4]. The loss (e.g. E-cadherin) and gain (e.g. carbohydrate ligand-binding epitopes) of key adhesion molecules are contributing factors in the metastatic process [11], [12]. This study investigated two interesting exceptions to the above rule, namely the inflammatory breast cancer model, MARY-X and a canine mammary carcinoma model. Both models are highly metastatic, yet display neither a loss in E-cadherin expression nor overall gain in the carbohydrate ligand-binding epitope of endothelial cells, sLex[25], [26]. Rather, these two exceptions suggest a more "adaptable" metastatic progression as opposed to a "one way" progression from the invasive (loss of E-cadherin expression) to malignant phenotype (gain in sLex expression). The heterogeneous population of cellular expression suggests a dynamic "back and forth" transition state between phenotypes that might promote survival of the tumor embolus during metastatic progression.
###end p 50
###begin p 51
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
Our study shows a correlated inverse relationship of E-cadherin and sLex expression in the genesis, dissemination and subsequent metastases in the MARY-X and canine mammary carcinoma models. These preliminary findings suggest that loss and gain in expression of adhesion molecules is not an aberrant variation but rather an adaptive cellular and molecular mechanism of the cancer that contribute to its metastatic ability. Our findings are the beginning to a better understanding of these adaptive mechanisms. More specifically, since molecular variation contributes to cancer progression and survival then the present findings set the ground for targeting these mechanisms resulting in new therapeutic strategies of metastatic disease. Further work is in progress regarding the clarification of the molecular mechanism underlying gene expression of these two key molecules through out the metastatic progression in both comparative models.
###end p 51
###begin p 52
###xml 109 110 109 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</sup>
In conclusion, our study suggests the existence of a biologically coordinated mechanism of E-cadherin and sLex expression (i.e. molecular plasticity) essential for tumor establishment and metastatic progression.
###end p 52
###begin p 53
We thank Prof. Eva Hellmen for providing the CMT-U27 carcinoma cell line. We would like to thank to Prof. Leonor David for helpful suggestions and discussion.
###end p 53
###begin title 54
References
###end title 54
###begin article-title 55
General Mechanisms of Metastasis.
###end article-title 55
###begin article-title 56
The Microenvironment of the Tumour-host Interface.
###end article-title 56
###begin article-title 57
Mechanisms of Metastasis: Epithelial-to-Mesenchymal Transition and Contribution of Tumor Microenvironment.
###end article-title 57
###begin article-title 58
Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.
###end article-title 58
###begin article-title 59
Metastasis: recent discoveries and novel treatment strategies.
###end article-title 59
###begin article-title 60
Adaptation versus Selection: The Origins of Metastatic Behavior.
###end article-title 60
###begin article-title 61
Clonal Selection of Metastasis within the Life History of a Tumor.
###end article-title 61
###begin article-title 62
Cell polarity in development and cancer.
###end article-title 62
###begin article-title 63
Epithelial-mesenchymal transition in breast cancer development.
###end article-title 63
###begin article-title 64
Metastases: the glycan connection.
###end article-title 64
###begin article-title 65
The E-cadherin-catenin complex in tumor metastasis: structure, function and regulation.
###end article-title 65
###begin article-title 66
Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis.
###end article-title 66
###begin article-title 67
Altered glycosylation in cancer: sialic acids and sialyltransferases.
###end article-title 67
###begin article-title 68
Sialidase and malignancy: a minireview.
###end article-title 68
###begin article-title 69
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins.
###end article-title 69
###begin article-title 70
###xml 46 50 <span type="species:ncbi:9615">dogs</span>
###xml 54 60 <span type="species:ncbi:9606">humans</span>
Translation of new cancer treatments from pet dogs to humans.
###end article-title 70
###begin article-title 71
###xml 34 39 <span type="species:ncbi:9606">human</span>
A comparative study of canine and human breast cancer.
###end article-title 71
###begin article-title 72
###xml 8 13 <span type="species:ncbi:9606">human</span>
A Novel human xenograft model of Inflammatory Breast Cancer.
###end article-title 72
###begin article-title 73
Canine mammary tumor cell lines established in vitro.
###end article-title 73
###begin article-title 74
Canine inflammatory mammary carcinoma: histopathology, immunohistochemistry and clinical implications of 21 cases.
###end article-title 74
###begin article-title 75
First description of feline inflammatory mammary carcinoma: clinicopathological and immunohistochemical characteristics of three cases.
###end article-title 75
###begin article-title 76
An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
###end article-title 76
###begin article-title 77
Cooperative role of e-cadherin and sialyl-lewis x/a-deficient muc1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.
###end article-title 77
###begin article-title 78
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x/a</sup>
Relationship of sialyl-lewisx/a underexpression and e-cadherin overexpression in the lymphovascular embolus of inflammatory breast carcinoma.
###end article-title 78
###begin article-title 79
Sialyl Lewis x expression in canine malignant mammary tumors: correlation with clinicopathological features and E-cadherin expression.
###end article-title 79
###begin article-title 80
Inflammatory breast cancer: challenges and development.
###end article-title 80
###begin p 81
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 81
###begin p 82
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by grants from the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. Project grant [PTDC/CVT/65537/2006], financiado no ambito do Programa Operacional Ciencia e Inovacao 2010, do Quadro Comunitario de Apoio III e comparticipado pelo Fundo Europeu de Desenvolvimento Regional. S.S.Pinho acknowledges FCT (SFRH/BD/21693/2005) and Fundacao Luso-Americana (FLAD) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 82

